A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults
Public ClinicalTrials.gov record NCT02774668. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The present study is designed to examine the effect of changes in body weight and related parameters associated with a commercially-available, low-carbohydrate diet plan. A parameter proposed to be studied here is the impact of fructose restriction and weight loss on serum uric acid concentrations and arterial stiffness.
Study identification
- NCT ID
- NCT02774668
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2016
- Primary completion
- Mar 31, 2017
- Completion
- Mar 31, 2017
- Last update posted
- May 3, 2025
2016 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Missouri | Columbia | Missouri | 65212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Metabolic Syndrome trials
Other public records listing Metabolic Syndrome. Sorted by last update posted; newest first. Not a recommendation.
- NCT07797036: Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Not yet recruiting
- NCT07218653: Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome Not yet recruiting
- NCT07669168: Health Ahead Comparative Effectiveness Study Recruiting
- NCT07646782: Human Observatory Study Recruiting
- NCT07625332: Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI) Recruiting
- NCT04812314: Exercise Effects on Adipose Tissue Structure and Function Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02774668, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 3, 2025 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02774668 live on ClinicalTrials.gov.